相似文献
1
[Incidence of Kawasaki disease before and during the covid-19 pandemic in Peru].
Rev Colomb Reumatol. 2022 Jun;29:S88-S89. doi: 10.1016/j.rcreu.2021.07.006. Epub 2021 Sep 7.
2
Kawasaki disease before and during the COVID-19 pandemic: a single-center comparative study in Switzerland.
BMC Pediatr. 2024 Oct 8;24(1):637. doi: 10.1186/s12887-024-05115-0.
3
Prevention Measures for COVID-19 and Changes in Kawasaki Disease Incidence.
J Epidemiol. 2021 Nov 5;31(11):573-580. doi: 10.2188/jea.JE20210132. Epub 2021 Sep 17.
4
Regional Differences in Kawasaki Disease Incidence Reduction Before and After the Onset of the Coronavirus Disease 2019 Pandemic.
J Pediatr. 2022 Nov;250:54-60.e5. doi: 10.1016/j.jpeds.2022.07.008. Epub 2022 Jul 16.
5
Impact of the COVID-19 pandemic on the incidence of dengue fever in Peru.
J Med Virol. 2022 Jan;94(1):393-398. doi: 10.1002/jmv.27298. Epub 2021 Sep 1.
6
Seasons of Kawasaki Disease during the COVID-19 pandemic.
Cardiol Young. 2024 Nov;34(11):2329-2332. doi: 10.1017/S1047951124036047. Epub 2024 Dec 4.
7
Kawasaki Disease and Respiratory Viruses: Ecological Spatiotemporal Analysis.
JMIR Public Health Surveill. 2024 Jul 25;10:e49648. doi: 10.2196/49648.
8
Characteristics of Kawasaki Disease Before and After the COVID-19 Pandemic in a Large Pediatric Heart Disease Center.
Front Pediatr. 2022 May 17;10:895408. doi: 10.3389/fped.2022.895408. eCollection 2022.
9
Multi-inflammatory syndrome and Kawasaki disease in children during the COVID-19 pandemic: A nationwide register-based study and time series analysis.
Acta Paediatr. 2021 Nov;110(11):3063-3068. doi: 10.1111/apa.16051. Epub 2021 Aug 4.
10
Decreased incidence of Kawasaki disease in South Korea during the SARS-CoV-2 pandemic.
Front Pediatr. 2024 Apr 3;12:1307931. doi: 10.3389/fped.2024.1307931. eCollection 2024.
本文引用的文献
1
[Pediatric multisystemic inflammatory syndrome associated with COVID-19: preliminary report of a hospital in Peru].
Rev Peru Med Exp Salud Publica. 2021 Jan-Mar;38(1):180-182. doi: 10.17843/rpmesp.2021.381.6460. Epub 2021 Jun 25.
2
Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.
BMJ Paediatr Open. 2021 Apr 2;5(1):e001034. doi: 10.1136/bmjpo-2021-001034. eCollection 2021.
3
Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan.
JAMA Netw Open. 2021 Apr 1;4(4):e214475. doi: 10.1001/jamanetworkopen.2021.4475.
4
Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
Front Immunol. 2021 Feb 26;12:632890. doi: 10.3389/fimmu.2021.632890. eCollection 2021.
5
[Characterization of coronavirus disease 2019 (COVID-19) in children and adolescents in Latin American and the Caribbean countries: A descriptive study].
Medwave. 2020 Sep 16;20(8):e8025. doi: 10.5867/medwave.2020.08.8025.
6
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
7
Kawasaki Disease in Latin American Children: Past, Current, and Future Challenges.
J Pediatric Infect Dis Soc. 2014 Dec;3(4):280-1. doi: 10.1093/jpids/piu105. Epub 2014 Nov 5.
Zotero 插件